Flagship has just announced that it will work with biotech start-up ProFound Therapeutics to find first-in-class protein therapeutics with potential in obesity, confirming this is the first ...

While mRNA vaccines have received intense attention of late, another class of nucleic acid therapeutics has been growing steadily in recent years. Its impact could be equally profound. Nucleic ...